Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;10(12):5076-5084.
doi: 10.21037/tcr-21-1765.

Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer

Affiliations

Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer

Masakuni Sakaguchi et al. Transl Cancer Res. 2021 Dec.

Abstract

Background: Unintentional irradiation of the spleen may reduce absolute lymphocyte count (ALC), which can affect tumor immunity. Therefore, in the present study, we evaluated spleen dose-volume parameters associated with ALC and neutrophil/lymphocyte ratio (NLR) in patients with esophageal cancer.

Methods: This retrospective study evaluated patients who were diagnosed with stage I-IV esophageal cancer and who received radiotherapy at Nihon University Itabashi Hospital between January 2015 and March 2020. Spleen V5, V10, V20, and V30 and mean spleen dose, which are dose-volume histogram parameters correlated with ALC and NLR, were analyzed.

Results: In total, 89 esophageal cancer patients with a median age of 72 years (range, 51-92 years) were included in this research. Results showed that spleen V5, V10, and V20 and mean splenic dose were significantly correlated with a low ALC. Meanwhile, a significant association was observed between spleen V5 and V10 and a high NLR (P<0.05). In the linear regression analysis, spleen V5 and V10 were remarkably associated with a low ALC (P=0.006 and 0.008). Further, a correlation was noted between spleen V5 and a high NLR (P=0.019). Spleen V5 and V10 were remarkably associated with greater than grade 3 lymphopenia (P=0.024 and P=0.031).

Conclusions: A correlation was observed between the irradiated volume of the spleen and ALC and NLR in patients with esophageal cancer. Furthermore, the spleen should be regarded as a high-risk organ, and the use of techniques in reducing spleen V5, V10 for the preservation of tumor immunity may be beneficial.

Keywords: Absolute lymphocyte count (ALC); esophageal cancer; neutrophil/lymphocyte ratio (NLR); radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/tcr-21-1765). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Correlations between spleen dose volume parameters and ALC during radiotherapy in patients with esophageal cancer. ALC, absolute lymphocyte count.
Figure 2
Figure 2
Correlations between spleen dose volume parameters and NLR during radiotherapy in patients with esophageal cancer. NLR, neutrophil/lymphocyte ratio.

References

    1. van Rossum PSN, Mohammad NH, Vleggaar FP, et al. Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends. Nat Rev Gastroenterol Hepatol 2018;15:235-49. 10.1038/nrgastro.2017.162 - DOI - PubMed
    1. Hironaka S, Ohtsu A, Boku N, et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003;57:425-33. 10.1016/S0360-3016(03)00585-6 - DOI - PubMed
    1. Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:2697-702. 10.1200/JCO.2003.03.055 - DOI - PubMed
    1. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005;5:606-16. 10.1038/nri1669 - DOI - PubMed
    1. Showalter A, Limaye A, Oyer JL, et al. Cytokines in immunogenic cell death: Applications for cancer immunotherapy. Cytokine 2017;97:123-32. 10.1016/j.cyto.2017.05.024 - DOI - PMC - PubMed